Abstract
The purpose of this study is to investigate the clinical and serological associations of anti-ribosomal P0 protein antibodies (anti-Rib-P0) in patients with systemic lupus erythematosus (SLE). The sera of 470 patients with SLE and 124 patients with primary Sjogren’s Syndrome (pSS) were collected. Line immunoassay (LIA) was used to detect anti-Rib-P0 and other related antibodies. A complete laboratory evaluation and clinical examination were also performed in each SLE patient. The prevalence of anti-Rib-P0 in SLE patients was significantly higher than that in pSS patients (35.74 vs 6.45%) (P < 0.001). There was a significantly lower prevalence of cardiac involvement in anti-Rib-P0-positive SLE patients compared to anti-Rib-P0-negative SLE patients (P = 0.019); no significant associations of anti-Rib-P0 antibodies with encephalopathy manifestations and other vital organs involvement were observed. Anti-nucleosomes, anti-dsDNA, anti-Histones, anti-SmD1, and anti-U1snRNP were significantly associated with serum anti-Rib-P0 antibodies positivity in SLE patients (all P < 0.05). The sensitivity and specificity of the anti-Rib-P0 antibodies to diagnose SLE were 35.74 and 93.55%, respectively. There is a higher prevalence of anti-Rib-P0 in SLE patients. Anti-Rib-P0 positivity may indicate lower cardiac involvement for SLE patients. It may serve as an important complementary parameter in SLE, in addition to anti-dsDNA, anti-SmD1, and anti-nucleosomes.
Similar content being viewed by others
References
Viana VT, Durcan L, Bonfa E, Elkon KB (2017) Ribosomal P antibody: 30 years on the road. Lupus 26(5):453–462. https://doi.org/10.1177/0961203317690243
Elkon KB, Parnassa AP, Foster CL (1985) Lupus autoantibodies target ribosomal P proteins. J Exp Med 162(2):459–471
Francoeur AM, Peebles CL, Heckman KJ, Lee JC, Tan EM (1985) Identification of ribosomal protein autoantigens. J Immunol 135(4):2378–2384
Mahler M, Kessenbrock K, Raats J, Williams R, Fritzler MJ, Bluthner M (2003) Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J Mol Med (Berl) 81(3):194–204. https://doi.org/10.1007/s00109-003-0423-1
Elkon K, Skelly S, Parnassa A, Moller W, Danho W, Weissbach H, Brot N (1986) Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci U S A 83(19):7419–7423
Hasler P, Brot N, Weissbach H, Danho W, Blount Y, Zhou JL, Elkon KB (1994) The effect of phosphorylation and site-specific mutations in the immunodominant epitope of the human ribosomal P proteins. Clin Immunol Immunopathol 72(2):273–279
Sato T, Uchiumi T, Ozawa T, Kikuchi M, Nakano M, Kominami R, Arakawa M (1991) Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 18(11):1681–1684
Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R (1992) Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 51(9):1053–1055
Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB (1996) Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 39(11):1833–1839
Mahler M, Kessenbrock K, Szmyrka M, Takasaki Y, Garcia-De La Torre I, Shoenfeld Y, Hiepe F, Shun-le C, von Muhlen CA, Locht H, Hopfl P, Wiik A, Reeves W, Fritzler MJ (2006) International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 13(1):77–83. https://doi.org/10.1128/CVI.13.1.77-83.2006
Teh LS, Lee MK, Wang F, Manivasagar M, Charles PJ, Nicholson GD, Hay EM, Isenberg DA, Amos N, Williams BD (1993) Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheumatol 32(8):663–665
Haddouk S, Marzouk S, Jallouli M, Fourati H, Frigui M, Hmida YB, Koubaa F, Sellami W, Baklouti S, Hachicha J, Bahloul Z, Masmoudi H (2009) Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatology (Oxford) 48(8):953–957. https://doi.org/10.1093/rheumatology/kep142
Shi ZR, Cao CX, Tan GZ, Wang L (2015) The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis. Lupus 24(6):588–596. https://doi.org/10.1177/0961203314560003
Valoes CC, Molinari BC, Pitta AC, Gormezano NW, Farhat SC, Kozu K, Sallum AM, Appenzeller S, Sakamoto AP, Terreri MT, Pereira RM, Magalhaes CS, Ferreira JC, Barbosa CM, Gomes FH, Bonfa E, Silva CA, Brazilian Childhood-onset Systemic Lupus Erythematosus G (2017) Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients. Lupus 26(5):484–489. https://doi.org/10.1177/0961203316676386
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/1529–0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61(6):554–558
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1999). Arthritis Rheum 42(4):599–608. doi:https://doi.org/10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
Bravo-Zehnder M, Toledo EM, Segovia-Miranda F, Serrano FG, Benito MJ, Metz C, Retamal C, Alvarez A, Massardo L, Inestrosa NC, Gonzalez A (2015) Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis Rheumatol 67(1):204–214. https://doi.org/10.1002/art.38900
Barkhudarova F, Dahnrich C, Rosemann A, Schneider U, Stocker W, Burmester GR, Egerer K, Schlumberger W, Hiepe F, Biesen R (2011) Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus. Arthritis Res Ther 13(1):R20. https://doi.org/10.1186/ar3244
Li J, Shen Y, He J, Jia R, Wang X, Chen X, Wang D, Han L, Zhu L, Chi X, Saschenbrecker S, Dahnrich C, Stocker W, Schlumberger W, Li ZG (2013) Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus. J Clin Lab Anal 27(2):87–95. https://doi.org/10.1002/jcla.21543
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (81573222).
Author information
Authors and Affiliations
Contributions
H.-F.P. and Z.-J.L. designed the study; Y.-J.M., P.W., C.J., T.W., and L.-J.C. performed the experiments; Y.-J.M. and P.W. collected and analyzed the data; Y.-J.M. wrote the paper; H.-F.P. reviewed the paper.
Corresponding authors
Ethics declarations
Disclosures
None.
Additional information
Yong-Jun Mei and Peng Wang should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Mei, YJ., Wang, P., Jiang, C. et al. Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus. Clin Rheumatol 37, 703–707 (2018). https://doi.org/10.1007/s10067-017-3886-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3886-0